The TLR4–NF-κB pathway has been intensively studied in several cancers such as laryngeal carcinoma and ovarian carcinoma as prognostic markers and inhibiting of the pathway might serve as a potential treatment of the cancers. The gene discussed is NFKB1; the disease is cancer.